Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 297

1.

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.

Schauer IE, Snell-Bergeon JK, Bergman BC, Maahs DM, Kretowski A, Eckel RH, Rewers M.

Diabetes. 2011 Jan;60(1):306-14. doi: 10.2337/db10-0328. Epub 2010 Oct 26.

2.

Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes.

Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, Hainault I, Vexiau P, Mauvais-Jarvis F, Calvo F, Gautier JF.

Diabetes Care. 2008 Dec;31(12):2332-7. doi: 10.2337/dc08-0914. Epub 2008 Sep 22.

3.

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21.

PMID:
18474251
4.

Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction.

Kooner JS, Baliga RR, Wilding J, Crook D, Packard CJ, Banks LM, Peart S, Aitman TJ, Scott J.

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1021-6.

5.

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.

Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study.

Diabetes. 2003 Nov;52(11):2833-9. Erratum in: Diabetes. 2004 Aug;53(8):2177.

6.
7.

Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.

Llauradó G, Sevastianova K, Sädevirta S, Hakkarainen A, Lundbom N, Orho-Melander M, Groop PH, Forsblom C, Yki-Järvinen H.

J Clin Endocrinol Metab. 2015 Feb;100(2):607-16. doi: 10.1210/jc.2014-3050. Epub 2014 Nov 18.

PMID:
25405502
8.

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

Diabetes. 2001 Aug;50(8):1844-50.

9.

Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.

Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, Louche-Pellissier C, MaItrepierre C, Peyrat J, Chagné J, Vidal H, Laville M.

J Clin Endocrinol Metab. 2003 Oct;88(10):4917-23.

PMID:
14557474
10.

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

Diabetes Care. 1993 Oct;16(10):1347-55.

PMID:
8269792
11.

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285.

PMID:
8621019
12.

Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.

Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT.

Diabetes. 2001 Jun;50(6):1344-50.

13.

Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).

Vaag A, Lehtovirta M, Thye-Rönn P, Groop L; European Group of Insulin Resistance.

Diabet Med. 2001 Jul;18(7):533-40.

PMID:
11553181
14.

Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

Kruszynska YT, Olefsky JM, Frias JP.

Metabolism. 2003 Feb;52(2):233-8.

PMID:
12601639
15.

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.

PMID:
10909980
16.

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA.

Diabetes. 1993 May;42(5):764-72.

PMID:
8482434
17.

Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.

Jaumdally RJ, Lip GY, Patel JV, MacFadyen RJ, Varma C.

J Intern Med. 2009 Jun;265(6):689-97. doi: 10.1111/j.1365-2796.2009.02072.x. Epub 2009 Feb 16.

18.

Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.

Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG.

Diabetes. 2010 Jun;59(6):1349-57. doi: 10.2337/db09-0745. Epub 2010 Mar 18.

19.

Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.

Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H.

Diabetologia. 2001 Jul;44(7):824-33.

PMID:
11508266
20.

Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.

Galgani JE, Heilbronn LK, Azuma K, Kelley DE, Albu JB, Pi-Sunyer X, Smith SR, Ravussin E; Look AHEAD Adipose Research Group.

Diabetes. 2008 Apr;57(4):841-5. doi: 10.2337/db08-0043. Epub 2008 Feb 19.

Supplemental Content

Support Center